A daily aspirin cuts cancer, but doctors say don't reach for the bottle yet. March 20, 2012— -- A daily aspirin may cut your risk of cancer, new research suggests. But doctors advise that there's ...

Scientists have described the “Eureka moment” when they discovered how aspirin may prevent some cancers from spreading. Their new research builds on existing evidence and suggests aspirin supports a ...

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...

HealthDay News — Regular aspirin use significantly reduced risk of cancer, metastasis and cancer mortality, findings from the largest-ever analyses exploring the drug’s effects on cancer indicate.

Taking low-dose aspirin long term may help prevent the development and progression of colorectal cancer, according to new research. A study published this week in Cancer, a peer-reviewed journal of ...

Just two aspirin a week may help reduce the risk of colorectal cancer in adults living unhealthy lifestyles, new research from Mass General Brigham finds. Nearly 108,000 health professionals were ...

Study reveals that aspirin helps the body’s immune system detect and target cancer cells. Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but ...

Your everyday pain reliever might be doing more than just easing headaches. A major new study published in JAMA Oncology reveals that regular aspirin use could significantly lower the risk of ...

Aspirin has the potential to prevent certain forms of cancer from spreading, scientists have found, and could even be used as a cancer treatment in the future. New research from a University of ...

Aspirin remains one of the most inexpensive drugs in the pharmacy. A familiar brand-name tablet costs less than 6 cents a pill. A bottle containing 300 tablets will set you back under $17. Despite the ...

An innovative new study is trialing whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.

The use of low-dose aspirin among older people shows no effect in reducing the incidence of certain cancer types. However, the treatment — particularly with frequency of at least three times a week — ...